Advertisement

Topics

AstraZeneca Sells Remaining Anesthetics Portfolio to Aspen in $766M Deal

09:25 EDT 14 Sep 2017 | PharmPro

Aspen Global Incorporated (AGI) is set to purchase the remaining rights to AstraZeneca's portfolio of anesthetics for approximately $766 million. 
Staff Author: 
Topics: 

Original Article: AstraZeneca Sells Remaining Anesthetics Portfolio to Aspen in $766M Deal

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca Sells Remaining Anesthetics Portfolio to Aspen in $766M Deal"

Quick Search
Advertisement
 

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...